Brain scintigraphy with 99mTc-tetrofosmin for the differential diagnosis of a posterior fossa tumor

Hellenic Journal of Nuclear Medicine

Volumn 11, Issue 2, 2008, Pages 114-117

  Alexiou, George A ^a   Tsiouris, Spyridon ^a   Voulgaris, Spyridon ^a   Doukas, Mihalis ^a   Goussia, Ann ^a   Kyritsis, Athanasios P ^a   Polyzoidis, Konstantinos S ^a   Fotopoulos, Andreas D ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

99mTc tetrofosmin; Central Nervous System; Diagnosis; Haemangioblastoma; Posterior fossa; SPET

Indexed keywords

CD31 ANTIGEN; KI 67 ANTIGEN; PERTECHNETIC ACID TC 99M; TETROFOSMIN TC 99M; VIMENTIN; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE;

ADULT; ARTICLE; BRAIN RADIOGRAPHY; BRAIN SCINTISCANNING; CANCER SURGERY; CASE REPORT; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; EQUIPMENT DESIGN; FEMALE; GLIOMA; HEADACHE; HEMANGIOBLASTOMA; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CRANIAL FOSSA TUMOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; CEREBELLUM; CEREBELLUM TUMOR; DIFFERENTIAL DIAGNOSIS; MIDDLE AGED; SCINTISCANNING;

CEREBELLAR NEOPLASMS; CEREBELLUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMANGIOBLASTOMA; HUMANS; INFRATENTORIAL NEOPLASMS; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS;

EID: 51549105913     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 2003; 33: 148-162.
2. 18F-fluorodeoxyglucose. J Neurooncol 2000; 46: 63-70.
3. Vega-Basulto S, Silva-Adan S, Penones-Montero R, Mosqueda-Betancourt G. Haemangioblastomas of the central nervous system in Camaguey (Cuba) Rev Neurol 2002; 35: 512-516.
4. Prieto R, Roda JM. Haemangioblastoma of the lateral ventricle: case report and review of the literature. Neurocirugia (Astur) 2005; 16: 58-62.
5. Neumann HP, Eggert HR, Weigel K et al. Haemangioblastomas of the central nervous system: A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 1989; 70: 24-30.
6. Catapano D, Muscarella LA, Guamieri V et al. Haemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Neurosurgery 2005; 56: 1215-1221.
7. Surawicz TS, McCarthy BJ, Kupelian V et al. Descriptive epidemiology of the primary brain and CNS tumors: Results from the Central Brain Tumor Registry of the United States, 1990-1994. Neurooncol 1999; 1: 14-25.
8. Glasker S, Van Velthoven V. Risk of hemorrhage in haemangioblastomas of the central nervous system. Neurosurgery 2005; 57: 71-76.
9. Julow J, Balint K, Gortvai P, Pasztor E. Posterior fossa blastomas. Acta Neurochir (Wien) 1994; 128: 109-114.
10. Dwarakanath S, Suri A, Sharma BS, Mehta VS. Intracranial hemangioblastomas: an institutional experience. Neurol India 2006; 54: 276-278.
11. Heiserman JE, Dean BL, Hodak JA et al. Neurologic complications of cerebral angiography. Am J Neuroradiol 1994; 15: 1401-1407.
12. Willinsky RA, Taylor SM, TerBrugge K et al. Neurologic complications of cerebral angiography: prospective analysis of 2,899 procedures and review of the literature. Radiology 2003; 227: 522-528.
13. 201TI chloride in patients with malignant brain tumours. Nucl Med Commun 2001; 22: 631-639.
14. 99mTc-L-methionine brain SPET for detection of recurrent brain tumor: a pilot study with radiological and pathological correlation. Acta Radiol 2004; 45: 649-657.
15. Weber W, Bartenstein P, Gross MW et al. Fluorine-18-FDG PET and iodine-123-IMT SPET in the evaluation of brain tumors. J Nucl Med 1997; 38: 802-808.
16. Kelly JD, Forster AM, Higley B et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222-227.
17. 99m-Tc-tetrofosmin. Ann Nucl Med 2004; 18: 79-95.
18. Platts EA, North TL, Pickett RD. Mechanism of uptake of technetium-tetrofosmin. I. Uptake into isolated adult rat ventricular myocytes and subcellular localization. J Nucl Cardiol 1995; 2: 317-326.
19. 99mTc-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells. Cancer Biother Radiopharm 2005; 20: 249-259.
20. 99mTc-tetrofosmin uptakes: a comparative study in sensitive U-87-MG and multidrug-resistant MRP1 human glioma cells. Cancer Biother Radiopharm 2004; 19: 411-421.
21. Soricelli A, Cuocolo A, Varrone A et al. Technetium-99m-tetrofosmin uptake in brain tumors by SPET: comparison with thallium-201 imaging. J Nucl Med 1998; 39:802-806.
22. 99mTc-tetrofosmin SPET: a prospective pilot study. Ann Nucl Med 2007; 21: 293-298.
23. Alexiou G, Tsiouris S, Fotopoulos A. Single-photon emission computed tomography in the evaluation of brain tumors and the diagnosis of relapse vs radiation necrosis Hell J Nucl Med 2007; 10: 205-208.
24. 99mTc-Tetrofosmin SPECT for the detection of glioma recurrence. Eur J Nucl Med Mol Imaging 2008; May 20 (Epub ahead of print).
25. 99mTc-Tetrofosmin. Aeuro Oncol 2008; 10: 104-105.
26. 99mTc-Tetrofosmin brain SPET in prognostic assessment of high-grade gliomas. Radiother Oncol 2008; 86: 290.
27. 99mTc-tetrofosmin. Eur J Nucl Med Mol Imaging 2007; 34: 2143-2144.
28. 99mTc-Tetrofosmin SPET. Clin Neurol Neurosurg doi:10.1016/j.clineuro.2008.03.016
29. 99mTc-Tetrofosmin brain SPECT in the assessment of meningiomas - correlation with histological grade and proliferation index. J Neurooncol DOI: 10.1007/ s11060-008-9611-8
30. 99mTc-Tetrofosmin SPET for the differentiation of a cerebellar hemorrhage mimicking a brain metastasis from a renal cell carcinoma. J Neurooncol 2006; 78: 207-208.
31. Kondo T, Kumabe T, Maruoka S, Yoshimoto T. Diagnostic value of 201TI-single-photon emission computerized tomography studies in cases of posterior fossa haemangioblastomas. J Neurosurg 2001; 95: 292-297.
32. Barai S, Bandopadhayaya GP, Naik K, Haloi AK. Is brain SPET a suitable modality for evaluation of postradiotherapy posterior fossa brain tumours? A comparative evaluation with contrast enhanced computed tomography. J Indian Med Assoc 2004; 102: 477-479.